News
Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...
CII Telangana to hold ‘Pillars of Protection’ conference on pharma & chemical industries safety on June 25 at Hyderabad: Our Bureau, Bengaluru Tuesday, June 10, 2025, 09:00 Hr ...
Biocon Foundation with NCBS & BeST Cluster launches BioWISE Programme to empower women in STEM: Our Bureau, Bengaluru Monday, ...
Peethaambaran Kunnathoor, Chennai Tuesday, June 10, 2025, 08:00 Hrs [IST] ...
Experts support Centre’s ban on medical representatives from Central govt hospitals for sales promotion: Shardul Nautiyal, Mumbai Tuesday, June 10, 2025, 08:00 Hrs [IST] Followi ...
DHN unveils landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI emerges as top priority: Our ...
Hospitals work on data protection for responsible patient care: Dr Sameer Bhati: Nandita Vijayasimha, Bengaluru Tuesday, June 10, 2025, 08:00 Hrs [IST] Healthcare systems are incr ...
The leading 30 pharmaceutical companies, with revenues above Rs 2,500 crore, have registered robust net profit growth of 31 per cent during the financial year 2024-25 on account of new product ...
CDSCO, DAHD to form JWG to monitor use of antimicrobials in animals: Gireesh Babu, New Delhi Tuesday, June 10, 2025, 08:00 Hrs [IST] In an effort to control the use of antimicrobi ...
Mediar Therapeutics doses first patient in phase 2 WISPer trial of MTX-463 for idiopathic pulmonary fibrosis: Boston Monday, June 9, 2025, 15:00 Hrs [IST] Mediar Therapeutics, Inc ...
MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...
Sharda Care Healthcity appoints Dr Atampreet Singh as its senior director & head: Our Bureau, Bengaluru Monday, June 9, 2025, 14:45 Hrs [IST] Sharda Care Healthcity has appointed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results